Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced the wholesale acquisition cost (WAC) for AMPYRA (dalfampridine) Extended Release Tablets will be ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE